4Q 2018 Results and preliminary annual report

01. Mar 2019 | 1 min read

Moss, 28 February 2019
 
Gentian Diagnostics AS announces its results for the 4th quarter and 2018 preliminary annual results. The highlights include:
 
  • Record sales revenues of MNOK 11.1 for the quarter
  • 42 % growth in underlying sales revenue compared to 4Q17, 43 % year to date
  • All time high sales results achieved with fCAL® turbo

 

 
Please find the report here:  GDAS 2018 4Q Interim report[2594] or on Oslo Børs NewsWeb.
 
For further information, please contact:
 
Hilja Ibert
CEO, Gentian Diagnostics
E-mail: hilja.ibert@gentian.no
Cell Phone: +47 919 05 242
 
Njaal Kind
CFO, Gentian Diagnostics
E-mail: njaal.kind@gentian.no
Cell Phone. +47 919 06 525

You may also read


May 06, 2026 - Ole Sørlie

Gentian Diagnostics: First quarter 2026 report

Moss, 6 May 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic tests,..

Read more

May 06, 2026 - Ole Sørlie

Gentian Diagnostics ASA terminates NT-proBNP assay development

Moss, 6 May 2026 Following a comprehensive review of performance data and market dynamics, Gentian..

Read more

May 06, 2026 - Ole Sørlie

Gentian Diagnostics: Ex dividend NOK 0.60 today

Moss, 6 May 2026 The shares in Gentian Diagnostics ASA will be traded ex dividend NOK 0.60 as of today. The..

Read more